Latest news with #OxiDx
Sydney Morning Herald
2 days ago
- Health
- Sydney Morning Herald
Proteomics streaks ahead with simple test for injured racehorses
Proteomics International is on track to deliver a world-first simple blood test in Australia this year to detect muscle damage in thoroughbred horses, which could revolutionise the way injuries are detected and monitored after a race. The company's 66 per cent-owned subsidiary OxiDx Limited has developed the blood test technology alongside researchers at The University of Western Australia. It uses a drop of dried blood to test for two protein biomarkers, which can identify the level of muscle damage in horses. Proteomics aims to launch the first-in-class OxiDx test in Australia this year, and then plans to expand into the United States via the company's accredited Californian reference laboratory. The company also has a clinical study underway to validate OxiDx's ability to predict muscle damage in racehorses, which will further support its commercialisation efforts. Proteomics says the test will offer trainers a simple way to objectively measure a horse's muscle injury recovery, allowing them to tailor training and racing schedules to optimise the animal's post-race recovery and potentially enhance their subsequent performance. 'OxiDx has the potential to empower trainers to monitor muscle recovery with precision, helping their racehorses achieve peak performance while prioritising equine health and well-being.' Proteomics International managing director Dr Richard Lipscombe Over the weekend, the company published the results of a study of the novel test in the peer-reviewed journal, Veterinary Medicine and Science, which showed its OxiDx oxidative stress tests could monitor muscle recovery in racehorses. Oxidative stress is caused by an overload of toxic oxidants - known as free radicals - which can overpower the body's natural defences, throwing the system off balance. For the study, a group of Australian trainers collected dried blood samples from 34 horses before and up to seven days post-race, which were analysed by an external pathology centre for two key protein biomarkers.
The Age
2 days ago
- Health
- The Age
Proteomics streaks ahead with simple test for injured racehorses
Proteomics International is on track to deliver a world-first simple blood test in Australia this year to detect muscle damage in thoroughbred horses, which could revolutionise the way injuries are detected and monitored after a race. The company's 66 per cent-owned subsidiary OxiDx Limited has developed the blood test technology alongside researchers at The University of Western Australia. It uses a drop of dried blood to test for two protein biomarkers, which can identify the level of muscle damage in horses. Proteomics aims to launch the first-in-class OxiDx test in Australia this year, and then plans to expand into the United States via the company's accredited Californian reference laboratory. The company also has a clinical study underway to validate OxiDx's ability to predict muscle damage in racehorses, which will further support its commercialisation efforts. Proteomics says the test will offer trainers a simple way to objectively measure a horse's muscle injury recovery, allowing them to tailor training and racing schedules to optimise the animal's post-race recovery and potentially enhance their subsequent performance. 'OxiDx has the potential to empower trainers to monitor muscle recovery with precision, helping their racehorses achieve peak performance while prioritising equine health and well-being.' Proteomics International managing director Dr Richard Lipscombe Over the weekend, the company published the results of a study of the novel test in the peer-reviewed journal, Veterinary Medicine and Science, which showed its OxiDx oxidative stress tests could monitor muscle recovery in racehorses. Oxidative stress is caused by an overload of toxic oxidants - known as free radicals - which can overpower the body's natural defences, throwing the system off balance. For the study, a group of Australian trainers collected dried blood samples from 34 horses before and up to seven days post-race, which were analysed by an external pathology centre for two key protein biomarkers.
The Age
15-05-2025
- Business
- The Age
Proteomics bags Chinese patent for innovative muscle stress test
A 66 per cent-owned subsidiary of ASX-listed Proteomics International Laboratories has picked up a major win in the world's most populous market after being granted a Chinese patent for its potentially revolutionary muscle stress test. Developed alongside The University of Western Australia, OxiDx Limited's technology uses a quick, low-cost fingerprick blood test to track muscle damage caused by oxidative stress in elite athletes and thoroughbred racehorses. Oxidative stress is caused by an overload of toxic oxidants - known as free radicals, which start to overpower the body's natural defences, throwing the system off balance. It is also linked to more than 70 different human health conditions. The test can be done anywhere, from a lab at home or on the track to deliver instant feedback that can help manage training, injury recovery and even early intervention for chronic health issues such as cancer and diabetes. Muscle injuries account for up to 55 per cent of all sports injuries in professional athletes. The horse racing industry fares even worse, with 85 per cent of thoroughbreds suffering at least one injury by the time they finish their second racing season. Proteomics says the freshly granted Chinese patent effectively future proofs the company's competitive advantage in Asia and remains valid until 2039. The commercial potential of the test appears enormous, particularly in a performance-obsessed market like China, where sports science, wellness, and elite horse racing are all booming. The new patent has also added serious firepower to OxiDx's global intellectual property footprint, which already covers the US, Japan, Europe and Australia. Second-generation protections are still in the pipeline for key markets such as Singapore, India and a fresh round in the US. Proteomics lit up the diagnostics scene in December when its OxiDx test holed out a proof-of-concept trial, tracking muscle damage and recovery in elite marathon runners with pinpoint accuracy.
Sydney Morning Herald
15-05-2025
- Business
- Sydney Morning Herald
Proteomics bags Chinese patent for innovative muscle stress test
A 66 per cent-owned subsidiary of ASX-listed Proteomics International Laboratories has picked up a major win in the world's most populous market after being granted a Chinese patent for its potentially revolutionary muscle stress test. Developed alongside The University of Western Australia, OxiDx Limited's technology uses a quick, low-cost fingerprick blood test to track muscle damage caused by oxidative stress in elite athletes and thoroughbred racehorses. Oxidative stress is caused by an overload of toxic oxidants - known as free radicals, which start to overpower the body's natural defences, throwing the system off balance. It is also linked to more than 70 different human health conditions. The test can be done anywhere, from a lab at home or on the track to deliver instant feedback that can help manage training, injury recovery and even early intervention for chronic health issues such as cancer and diabetes. Muscle injuries account for up to 55 per cent of all sports injuries in professional athletes. The horse racing industry fares even worse, with 85 per cent of thoroughbreds suffering at least one injury by the time they finish their second racing season. Proteomics says the freshly granted Chinese patent effectively future proofs the company's competitive advantage in Asia and remains valid until 2039. The commercial potential of the test appears enormous, particularly in a performance-obsessed market like China, where sports science, wellness, and elite horse racing are all booming. The new patent has also added serious firepower to OxiDx's global intellectual property footprint, which already covers the US, Japan, Europe and Australia. Second-generation protections are still in the pipeline for key markets such as Singapore, India and a fresh round in the US. Proteomics lit up the diagnostics scene in December when its OxiDx test holed out a proof-of-concept trial, tracking muscle damage and recovery in elite marathon runners with pinpoint accuracy.
